cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25573/data.10042556.v6
title: Bocas del Toro, Platform Tower_Relative Humidity

description: Bocas del Toro Research Station, TowerLocation: 9.351553°, -82.256565°<br>Relative Humidity, Interval max/min/avg<br>Sensors located on a platform located approximately 60m from the end of the station’s dock. Platform includes meteorlogical tower, Sea Surface Temperature probe and several sea level sensors. The current platform was built in 2012 to replace the original platform.<br>
DOI: 10.25573/data.10042574.v6
title: Bocas del Toro, Platform Tower_Water Temperature

description: Bocas del Toro Research Station, TowerLocation: 9.351553°, -82.256565°<br>Temperature, Interval average<br><br>Sensors located on a platform located approximately 60m from the end of the station’s dock. Platform includes meteorological tower, Sea Surface Temperature probe and several sea level sensors. The current platform was built in 2012 to replace the original platform.<br>
DOI: 10.25573/data.10042523.v6
title: Bocas del Toro, Platform Tower_Solar Radiation, Pyranometer

description: Bocas del Toro Research Station, TowerLocation: 9.351553°, -82.256565°<br>Solar Radiation, Pyranometer, Interval max/min/avg<br><br>Sensors located on a platform located approximately 60m from the end of the station’s dock. Platform includes meteorlogical tower, Sea Surface Temperature probe and several sea level sensors. The current platform was built in 2012 to replace the original platform.<br>
DOI: 10.25573/data.10042466.v6
title: Barro Colorado Island, AVA tower_Precipitation

description: Barro Colorado Island, AVA tower.<br>Precipitation, electronic tipping bucket<br><br>Established in Mar, 2011 as part of the ForestGEO Tropical Ecology, Assessment and Monitoring (TEAM) project.<br>The original tower was Located near the center of the island at the north west corner of the 50ha plot (9.1568°, -79.8486°).<br>In 2018 this tower was struck by a tree fall and rendered unusable.<br>In Feb. 2019 a new 45m tower was build close by (9.1568°, -79.8486°). <br>
DOI: 10.25573/data.10042445.v6
title: Barro Colorado Island, AVA tower_Wind speed

description: Barro Colorado Island, AVA tower.Wind speed, electronic sensor, interval max/min/avg<br>Established in Mar, 2011 as part of the ForestGEO Tropical Ecology, Assessment and Monitoring (TEAM) project.<br>The original tower was Located near the center of the island at the north west corner of the 50ha plot (9.1568°, -79.8486°).<br>In 2018 this tower was struck by a tree fall and rendered unusable.<br>In Feb. 2019 a new 45m tower was build close by (9.1568°, -79.8486°). <br>
DOI: 10.21227/4v4k-k673
title: Switched-Beam End-Fire Antenna Array Fed by Wideband Via-Less Butler Matrix Based on Liquid Crystal Technology

description: Picture of the fabricated butler matrix fed end-fire antenna array.
DOI: 10.21227/ebvs-7p49
title: Switched-Beam End-Fire Antenna Array Fed by Wideband Via-Less Butler Matrix Based on Liquid Crystal Technology

description: Picture of the fabricated butler matrix fed end-fire antenna array.
DOI: 10.25573/data.10042454.v6
title: Barro Colorado Island, AVA tower_Wind direction

description: Barro Colorado Island, AVA tower.Mean vector, wind direction<br>Established in Mar, 2011 as part of the ForestGEO Tropical Ecology, Assessment and Monitoring (TEAM) project.<br>The original tower was Located near the center of the island at the north west corner of the 50ha plot (9.1568°, -79.8486°).<br>In 2018 this tower was struck by a tree fall and rendered unusable.<br>In Feb. 2019 a new 45m tower was build close by (9.1568°, -79.8486°). <br>
DOI: 10.25573/data.10042421.v6
title: Barro Colorado Island, AVA tower_Air Temperature

description: Barro Colorado Island, AVA tower.Air temperature, electronic sensor, interval max/min/avg<br>Established in Mar, 2011 as part of the ForestGEO Tropical Ecology, Assessment and Monitoring (TEAM) project.<br>The original tower was Located near the center of the island at the north west corner of the 50ha plot (9.1568°, -79.8486°).<br>In 2018 this tower was struck by a tree fall and rendered unusable.<br>In Feb. 2019 a new 45m tower was build close by (9.1568°, -79.8486°). <br>
DOI: 10.25573/data.10042448.v6
title: Barro Colorado Island, AVA tower_Relative Humdity

description: Barro Colorado Island, AVA tower.<br>Relative humidity, electronic sensor, interval max/min/avg<br><br>Established in Mar, 2011 as part of the ForestGEO Tropical Ecology, Assessment and Monitoring (TEAM) project.<br>The original tower was Located near the center of the island at the north west corner of the 50ha plot (9.1568°, -79.8486°).<br>In 2018 this tower was struck by a tree fall and rendered unusable.<br>In Feb. 2019 a new 45m tower was build close by (9.1568°, -79.8486°). <br>
DOI: 10.25573/data.10042439.v6
title: Barro Colorado Island, AVA tower_Solar Radiation, Pyranometer

description: Barro Colorado Island, AVA tower. <br>Two Sensors, North and South<br>Solar Radiation, Pyranometer, Interval max/min/avg<br><br>Established in Mar, 2011 as part of the ForestGEO Tropical Ecology, Assessment and Monitoring (TEAM) project.<br>The original tower was Located near the center of the island at the north west corner of the 50ha plot (9.1568°, -79.8486°).<br>In 2018 this tower was struck by a tree fall and rendered unusable.<br>In Feb. 2019 a new 45m tower was build close by (9.1568°, -79.8486°). <br>
DOI: 10.25573/data.10042412.v6
title: Barro Colorado Island, AVA tower_Solar Radiation, PAR

description: Barro Colorado Island, AVA tower.Two Sensors: North and South<br>Photosynthetically Active Radiation (PAR), Interval max/min/avg<br><br>Established in Mar, 2011 as part of the ForestGEO Tropical Ecology, Assessment and Monitoring (TEAM) project.<br>The original tower was Located near the center of the island at the north west corner of the 50ha plot (9.1568°, -79.8486°).<br>In 2018 this tower was struck by a tree fall and rendered unusable.<br>In Feb. 2019 a new 45m tower was build close by (9.1568°, -79.8486°). <br>
DOI: 10.6084/m9.figshare.13221191
title: Supplementary Material for: Impact of Medium Cut-Off Dialyzers on Patient-Reported Outcomes: COREXH Registry

description: <b><i>Introduction:</i></b> A new generation of hemodialysis (HD) membranes called medium cut-off (MCO) membranes possesses enhanced capacities for middle molecule clearance, which have been associated with adverse outcomes in this population. These improvements could potentially positively impact patient-reported outcomes (PROs). <b><i>Objective:</i></b> The objective of this study was to evaluate the impact of MCO membranes on PROs in a cohort of HD patients in Colombia. <b><i>Methods:</i></b> This was a prospective, multicenter, observational cohort study of 992 patients from 12 renal clinics in Colombia who were switched from high-flux HD to MCO therapy and observed for 12 months. Changes in Kidney Disease Quality of Life 36-Item Short Form Survey (KDQoL-SF36) domains, Dialysis Symptom Index (DSI), and restless legs syndrome (RLS) 12 months after switching to MCO membranes were compared with time on high-flux membranes. Repeated measures of ANOVA were used to evaluate changes in KDQoL-SF36 scores; severity scoring was used to assess DSI changes over time; Cochran’s Q test was used to evaluate changes in frequency of diagnostic criteria of RLS. <b><i>Results:</i></b> During 12 months of follow-up, 3 of 5 KDQoL-SF36 domains improved compared with baseline: symptoms (<i>p</i> &lt; 0.0001), effects of kidney disease (<i>p</i> &lt; 0.0001), and burden of kidney disease (<i>p</i> &lt; 0.001). The proportion of patients diagnosed with RLS significantly decreased from 22.1% at baseline to 10% at 12 months (<i>p</i> &lt; 0.0001). No significant differences in the number of symptoms (DSI, <i>p =</i> 0.1) were observed, although their severity decreased (<i>p</i> = 0.009). <b><i>Conclusions:</i></b> In conventional HD patients, the expanded clearance of large middle molecules with MCO-HD membranes was associated with higher health-related quality of life scores and a decrease in the prevalence of RLS.
DOI: 10.6084/m9.figshare.13221191.v1
title: Supplementary Material for: Impact of Medium Cut-Off Dialyzers on Patient-Reported Outcomes: COREXH Registry

description: <b><i>Introduction:</i></b> A new generation of hemodialysis (HD) membranes called medium cut-off (MCO) membranes possesses enhanced capacities for middle molecule clearance, which have been associated with adverse outcomes in this population. These improvements could potentially positively impact patient-reported outcomes (PROs). <b><i>Objective:</i></b> The objective of this study was to evaluate the impact of MCO membranes on PROs in a cohort of HD patients in Colombia. <b><i>Methods:</i></b> This was a prospective, multicenter, observational cohort study of 992 patients from 12 renal clinics in Colombia who were switched from high-flux HD to MCO therapy and observed for 12 months. Changes in Kidney Disease Quality of Life 36-Item Short Form Survey (KDQoL-SF36) domains, Dialysis Symptom Index (DSI), and restless legs syndrome (RLS) 12 months after switching to MCO membranes were compared with time on high-flux membranes. Repeated measures of ANOVA were used to evaluate changes in KDQoL-SF36 scores; severity scoring was used to assess DSI changes over time; Cochran’s Q test was used to evaluate changes in frequency of diagnostic criteria of RLS. <b><i>Results:</i></b> During 12 months of follow-up, 3 of 5 KDQoL-SF36 domains improved compared with baseline: symptoms (<i>p</i> &lt; 0.0001), effects of kidney disease (<i>p</i> &lt; 0.0001), and burden of kidney disease (<i>p</i> &lt; 0.001). The proportion of patients diagnosed with RLS significantly decreased from 22.1% at baseline to 10% at 12 months (<i>p</i> &lt; 0.0001). No significant differences in the number of symptoms (DSI, <i>p =</i> 0.1) were observed, although their severity decreased (<i>p</i> = 0.009). <b><i>Conclusions:</i></b> In conventional HD patients, the expanded clearance of large middle molecules with MCO-HD membranes was associated with higher health-related quality of life scores and a decrease in the prevalence of RLS.
DOI: 10.6084/m9.figshare.13221263
title: Table S1 resubmission.xslx

description: Proteomic analysis of iron-induced changes of B. natans.
DOI: 10.6084/m9.figshare.13221263.v1
title: Table S1 resubmission.xslx

description: Proteomic analysis of iron-induced changes of B. natans.
DOI: 10.6084/m9.figshare.13221218
title: Supplementary Material for: Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism

description: <b><i>Background:</i></b> This study aimed to determine whether use of oral anticoagulants (OACs) was associated with a reduced risk of recurrent stroke compared with use of antiplatelets (APs) in patients with embolic stroke of undetermined source (ESUS) having no potential source of embolism. <b><i>Methods:</i></b> Of 8,790 patients with acute ischemic stroke registered at 7 centers in the Fukuoka Stroke Registry from June 2007 to May 2017, we included 681 patients (mean age 69.7 [SD 14.1] years, 48.3% men) who experienced ESUS without a potential source of embolism and received OAC alone or AP alone. We estimated hazard ratios (HRs) and 95% confidential intervals (CIs) of recurrent ischemic stroke or any stroke after discharge using a Cox proportional hazards model and Fine and Gray model. <b><i>Results:</i></b> During a mean follow-up of 3.4 (SD 1.7) years, event rates of recurrent ischemic stroke were 4.4 per 100 person-years in 489 patients treated with AP and 2.0 per 100 person-years in 192 patients treated with OAC. OAC use was associated with a reduced risk of recurrent ischemic stroke, even after adjusting for potential confounding factors (multivariable-adjusted HR [95% CI], 0.42 [0.23–0.80]) and when additionally considering death as a competing risk (0.45 [0.24–0.85]). The reduced risk of recurrent ischemic stroke was still observed in patients treated with OAC (0.32 [0.15–0.67]) in reference to propensity score-matched patients treated with AP. These associations were maintained for all types of stroke, including ischemic and hemorrhagic stroke. <b><i>Conclusions:</i></b> This nonrandomized observational study suggests that anticoagulation therapy might be associated with a reduced risk of recurrent stroke compared with antiplatelet therapy in patients with ESUS in whom no potential source of embolism was identified. Further study should be performed in consideration of a potential source of embolism even in patients with ESUS.
DOI: 10.6084/m9.figshare.13221218.v1
title: Supplementary Material for: Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism

description: <b><i>Background:</i></b> This study aimed to determine whether use of oral anticoagulants (OACs) was associated with a reduced risk of recurrent stroke compared with use of antiplatelets (APs) in patients with embolic stroke of undetermined source (ESUS) having no potential source of embolism. <b><i>Methods:</i></b> Of 8,790 patients with acute ischemic stroke registered at 7 centers in the Fukuoka Stroke Registry from June 2007 to May 2017, we included 681 patients (mean age 69.7 [SD 14.1] years, 48.3% men) who experienced ESUS without a potential source of embolism and received OAC alone or AP alone. We estimated hazard ratios (HRs) and 95% confidential intervals (CIs) of recurrent ischemic stroke or any stroke after discharge using a Cox proportional hazards model and Fine and Gray model. <b><i>Results:</i></b> During a mean follow-up of 3.4 (SD 1.7) years, event rates of recurrent ischemic stroke were 4.4 per 100 person-years in 489 patients treated with AP and 2.0 per 100 person-years in 192 patients treated with OAC. OAC use was associated with a reduced risk of recurrent ischemic stroke, even after adjusting for potential confounding factors (multivariable-adjusted HR [95% CI], 0.42 [0.23–0.80]) and when additionally considering death as a competing risk (0.45 [0.24–0.85]). The reduced risk of recurrent ischemic stroke was still observed in patients treated with OAC (0.32 [0.15–0.67]) in reference to propensity score-matched patients treated with AP. These associations were maintained for all types of stroke, including ischemic and hemorrhagic stroke. <b><i>Conclusions:</i></b> This nonrandomized observational study suggests that anticoagulation therapy might be associated with a reduced risk of recurrent stroke compared with antiplatelet therapy in patients with ESUS in whom no potential source of embolism was identified. Further study should be performed in consideration of a potential source of embolism even in patients with ESUS.
DOI: 10.6084/m9.figshare.11955498
title: Dataset for paper "Spatiotemporal distribution of human trafficking in China and predicting the locations of missing persons"

description: The file (baby_find_home_data.txt) is data obtained from a Chinese public welfare website (https://baobeihuijia.com/) looking for missing children.<br>The code file can be found at the website: https://github.com/whuyao/Where_is_my_baby_code<br>This project uses two C ++ open source libraries (Alglib and CJsonObject). This project complies with the GPL license.<br>Alglib (https://www.alglib.net/) is an open source numerical analysis and data processing library for personal and academic use, developed for the ALGLIB Project Company. Detailed implementation of random forest algorithm used in this project. This library complies with the GPL license.<br>CJsonObject (https://github.com/Bwar/CJsonObject) is a C ++ version of the JSON open source library developed by Bwar based on CJSON. Used in this project for data reading and formatting output. This library complies with the MIT license.
DOI: 10.6084/m9.figshare.11955498.v6
title: Dataset and code for paper "Spatiotemporal distribution of human trafficking in China and predicting the locations of missing persons"

description: The file (baby_find_home_data.txt) is data obtained from a Chinese public welfare website (https://baobeihuijia.com/) looking for missing children.<br>The file (code_v2.zip) is a code file implemented by an under review paper ("Spatiotemporal distribution of human trafficking in China and predicting the locations of missing persons").<br>This project uses two C ++ open source libraries (Alglib and CJsonObject). This project complies with the GPL license.<br>Alglib (https://www.alglib.net/) is an open source numerical analysis and data processing library for personal and academic use, developed for the ALGLIB Project Company. Detailed implementation of random forest algorithm used in this project. This library complies with the GPL license.<br>CJsonObject (https://github.com/Bwar/CJsonObject) is a C ++ version of the JSON open source library developed by Bwar based on CJSON. Used in this project for data reading and formatting output. This library complies with the MIT license.
DOI: 10.6084/m9.figshare.13221245
title: Supplementary Material for: Alveolar Airspace Size in Healthy and Diseased Infant Lungs Measured via Hyperpolarized <sup>3</sup>He Gas Diffusion Magnetic Resonance Imaging

description: <b><i>Background:</i></b> Alveolar development and lung parenchymal simplification are not well characterized in vivo in neonatal patients with respiratory morbidities, such as bronchopulmonary dysplasia (BPD). Hyperpolarized (HP) gas diffusion magnetic resonance imaging (MRI) is a sensitive, safe, nonionizing, and noninvasive biomarker for measuring airspace size in vivo but has not yet been implemented in young infants. <b><i>Objective:</i></b> This work quantified alveolar airspace size via HP gas diffusion MRI in healthy and diseased explanted infant lung specimens, with comparison to histological morphometry. <b><i>Methods:</i></b> Lung specimens from 8 infants were obtained: 7 healthy left upper lobes (0–16 months, post-autopsy) and 1 left lung with filamin-A mutation, closely representing BPD lung disease (11 months, post-transplantation). Specimens were imaged using HP <sup>3</sup>He diffusion MRI to generate apparent diffusion coefficients (ADCs) as biomarkers of alveolar airspace size, with comparison to mean linear intercept (<i>L</i><sub>m</sub>) via quantitative histology. <b><i>Results:</i></b> Mean ADC and <i>L</i><sub>m</sub> were significantly increased throughout the diseased specimen (ADC = 0.26 ± 0.06 cm<sup>2</sup>/s, <i>L</i><sub>m</sub> = 587 ± 212 µm) compared with healthy specimens (ADC = 0.14 ± 0.03 cm<sup>2</sup>/s, <i>L</i><sub>m</sub> = 133 ± 37 µm; <i>p</i> &lt; 1 × 10<sup>−7</sup>); increased values reflect enlarged airspaces. Mean ADCs in healthy specimens were significantly correlated to <i>L</i><sub>m</sub> (<i>r</i> = 0.69, <i>p</i> = 0.041). <b><i>Conclusions:</i></b> HP gas diffusion MRI is sensitive to healthy and diseased regional alveolar airspace size in infant lungs, with good comparison to quantitative histology in ex vivo specimens. This work demonstrates the translational potential of gas MRI techniques for in vivo assessment of normal and abnormal alveolar development in neonates with pulmonary disease.
DOI: 10.25573/data.10042727.v6
title: Agua Salud, Celestino Tower_Net Radiation 3 of 3

description: Agua Salud Celestino Tower, Net Radiation<br>Location 9.21142N, 79.72656W<br>Parameters: <br> albedo (soil albedo), 0-1 (statistics calculated only for data between 7am and 5pm)<br> dnwlwr (down-welling long wave radiation), W/m2<br> dnwsr (down-welling short wave radiation), W/m2<br> netlwr (net long wave radiation), W/m2<br> netswr (net short wave radiation), W/m2<br> netrad (net radiation), W/m2<br> radt (radiometer temperature), C<br> rdnwlwr (raw down-welling long wave radiation), W/m2<br> rupwlwr (raw upwelling long wave radiation), W/m2<br> upwlwr (upwelling long wave radiation), W/m2<br> upwswr (upwelling short wave radiation), W/m2<br> soilt (soil temperature), C<br><br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.25573/data.10042562.v6
title: Agua Salud, Celestino Tower_Evapotranspiration Index

description: Agua Salud Celestino Tower. <br>Location 9.21142N, 79.72656W<br>Calculated Evapotranspiration Index, interval total<br>Based on the short reference ASCE Standardized Reference Evapotranspiration equation using a tall reference calculation based on alfalfa.<br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.25573/data.10042583.v6
title: Agua Salud, Celestino Tower_Solar Radiation, Pyranometer

description: Agua Salud Celestino Tower. <br>Two sensors: North and South<br>Location 9.21142N, 79.72656W<br>Solar Radiation, Pyranometer, Interval average<br><br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.25573/data.10042547.v6
title: Agua Salud, Celestino Tower_Air Pressure

description: Agua Salud Celestino Tower. <br>Location 9.21142N, 79.72656W<br>Air Pressure, Interval average<br><br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.25573/data.10042571.v6
title: Agua Salud, Celestino Tower_Wind Speed

description: Agua Salud Celestino Tower. <br>Location 9.21142N, 79.72656W<br>Wind Speed, Interval max/min/avg<br><br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.25573/data.10042565.v6
title: Agua Salud, Celestino Tower_Precipitation

description: Agua Salud Celestino Tower. <br>Two sensors: north and south<br>Location 9.21142N, 79.72656W<br>Precipitation, interval total<br><br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.25573/data.10042580.v6
title: Agua Salud, Celestino Tower_Solar Radiation, PAR

description: Agua Salud Celestino Tower. Two sensors, North and South<br>Location 9.21142N, 79.72656W<br>Photosynthetically Active Radiation (PAR), interval average<br><br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.6084/m9.figshare.13221272
title: Professors' Responses (Feedback in Higher education).xlsx

description: This documents contains the opinions of Moroccan professors about feedback and their actual feedback practices before and during Covid-19. The data was collected through a questionnaire that was sent to the professors via email and through (MATE) an association of Moroccan Teachers
DOI: 10.6084/m9.figshare.13221272.v1
title: Professors' Responses (Feedback in Higher education).xlsx

description: This documents contains the opinions of Moroccan professors about feedback and their actual feedback practices before and during Covid-19. The data was collected through a questionnaire that was sent to the professors via email and through (MATE) an association of Moroccan Teachers
DOI: 10.25573/data.10042568.v6
title: Agua Salud, Celestino Tower_Air Temperature

description: Agua Salud Celestino Tower. <br>Location 9.21142N, 79.72656W<br>Air Temperature, interval max/min/avg<br><br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall
DOI: 10.25573/data.10042589.v6
title: Agua Salud, Celestino Tower_Relative Humidity

description: Agua Salud Celestino Tower. <br>Location 9.21142N, 79.72656W<br>Relative Humidity, interval max/min/avg<br>Established in 2015 and is located at the eastern edge of the Soberania Nation Park, in an area of pastures and forest patches. The tower is 40ft (12.2m) tall